Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

VXRT

Vaxart (VXRT)

Vaxart Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:VXRT
일자시간출처헤드라인심볼기업
2025/01/1503:40AllPennyStocks.comThis California-Based Biotech Found Massive Success Following DSMB ApprovalNASDAQ:VXRTVaxart Inc
2025/01/1422:00GlobeNewswire Inc.Vaxart Highlights Progress of COVID-19, Norovirus and Influenza ProgramsNASDAQ:VXRTVaxart Inc
2025/01/1409:55GlobeNewswire Inc.Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical TrialNASDAQ:VXRTVaxart Inc
2025/01/0106:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
2024/12/2723:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
2024/12/1806:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VXRTVaxart Inc
2024/12/0306:01GlobeNewswire Inc.Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateNASDAQ:VXRTVaxart Inc
2024/11/1922:00GlobeNewswire Inc.Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VXRTVaxart Inc
2024/11/1406:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VXRTVaxart Inc
2024/11/1406:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:VXRTVaxart Inc
2024/11/0722:00GlobeNewswire Inc.Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13NASDAQ:VXRTVaxart Inc
2024/10/2421:00GlobeNewswire Inc.Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024NASDAQ:VXRTVaxart Inc
2024/10/1521:00GlobeNewswire Inc.Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet NeedNASDAQ:VXRTVaxart Inc
2024/10/0905:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VXRTVaxart Inc
2024/10/0905:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
2024/10/0106:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
2024/10/0105:12GlobeNewswire Inc.Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateNASDAQ:VXRTVaxart Inc
2024/08/3021:00GlobeNewswire Inc.Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VXRTVaxart Inc
2024/08/2821:00GlobeNewswire Inc.Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical DysplasiaNASDAQ:VXRTVaxart Inc
2024/08/0905:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VXRTVaxart Inc
2024/08/0905:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:VXRTVaxart Inc
2024/08/0221:00GlobeNewswire Inc.Vaxart to Host Second Quarter 2024 Business Update and Financial Results Conference Call on August 8NASDAQ:VXRTVaxart Inc
2024/06/2019:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VXRTVaxart Inc
2024/06/1805:05GlobeNewswire Inc.Vaxart Provides Business UpdateNASDAQ:VXRTVaxart Inc
2024/06/1719:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VXRTVaxart Inc
2024/06/1419:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
2024/06/1408:07GlobeNewswire Inc.Vaxart Announces $40 Million Underwritten Offering of Common StockNASDAQ:VXRTVaxart Inc
2024/06/1406:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
2024/06/1405:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VXRTVaxart Inc
2024/06/1405:15GlobeNewswire Inc.Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateNASDAQ:VXRTVaxart Inc
 검색 관련기사 보기:NASDAQ:VXRT